Ability Pharma is working on a drug capable of inducing cancer cell death through autophagy. ABTL0812 has demonstrated clinical efficacy in a Phase II clinical trial...
The acquisition of Experteam is aimed at expanding Clonit's technical and scientific expertise and portfolio of products and services offered. Clonit, which was founded in 1987...
Some of the big companies in the biotech sector have already outlined their plans for the new phase. For now, the largest U.S. biotech companies have...
Rovi, Càrniques Celrà and Grupo Empresarial Costa have signed an investment and partners agreement that has led to the constitution of the company Glycopepton Biotech, currently...
The prices of the devices marketed by 24Genetics range from approximately 99 euros to 400 euros. The company offers different DNA tests: ancestry, nutrigenetic, pharmaceutical, health,...
Initial trial results for SPVN06 are expected in 2023, with first efficacy data expected in 2025. SparingVision is also developing SPVN20, a second gene therapy drug...
CaixaResearch promotes cutting-edge research in health and biomedicine. The "la Caixa" Foundation's call for health research supports 33 projects of excellence from universities and research centers...
Each of the clinics that make up IVI RMA's worldwide network (more than 65 clinics) is likely to pursue one or more of the lines of...
GE Healthcare is divided into four areas. The first is imaging (with X-ray equipment, for example), ultrasound, patient care solutions, and pharmaceuticals. The company's annual turnover...
The Catalan pharmaceutical company Grifols reduced its profit by 46% through June, a period in which it earned €144.1 million. In 2021, the pharmaceutical company specializing...